SB-300, Jaguar's Drug Product Candidate for the Treatment of Gastric Ulcers, Enables Continued Therapy in Performance Horses in Accordance with Standard Testing Guidelines

Results of Initial Study Show that Jaguar's Equine Product Candidate for Treatment of Gastric Ulcers May Offer Horse Owners an Additional Advantage in the Competition Horse World, where Requirements Exist for Animals to Compete Free from the Effect of Any Drugs

Sign up for our free eNews letter. We do not share our list and we send one per week. Select any of the topics below.

Wednesday

February 21, 2018

Thursday

February 22, 2018

Friday

February 23, 2018

Saturday

February 24, 2018

Sunday

February 25, 2018

Monday

February 26, 2018

Tuesday

February 27, 2018

Issue 113 ad